Author Archive: AZBio

Tucson To Host Globally Recognized Cancer Research Conference Feb. 25 And 26

Posted on by

 The world’s top scientific minds will convene at Tucson’s Hilton El Conquistador Resort February 25 and 26 to collaborate and share leading-edge developments in cancer diagnostics and treatment. The 10th Annual Tucson Symposium puts Tucson at the leading edge of cancer research, diagnostics and treatment, and promises to further the field of personalized medicine and positively impact medical practice all over the world. (PR Newswire: TUCSON, Ariz., Feb. 13, 2014 )Continue reading→

NCI SBIR Direct to Phase II Pilot Program

Posted on by

Direct to Phase II Pilot Program is here!
Jump Into New Funding Opportunities Now

Finding funding to continue your innovative cancer research can be difficult. Luckily, there’s some good news.

The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center is implementing the SBIR Direct to Phase II Pilot solicitation, PAR-14-088, per the 2011 SBIR & STTR Reauthorization Act, allowing applicants that have demonstrated the R&D and technical merit characteristic of a Phase I (R43) SBIR project to bypass Phase I and apply directly for SBIR Phase II grants.

We encourage you to review the opportunity below and consider applying.

 


Direct Phase II Pilot Program

The NCI SBIR Development Center welcomes qualified applicants to participate in the newly authorized Direct-to-Phase II SBIR grant mechanism. This program applies to SBIR only, NOT STTR.This program is designed to expand opportunities for small business concerns and accelerate the pace of technology development and commercialization. Applicants that have demonstrated the R&D and technical merit characteristic of a Phase 1 (R43) SBIR project are encouraged to apply.

Standard deadlines apply. The next application receipt date is April 5, 2014, 5:00PM local time.

 


NIH SBIR and STTR applicants may now switch programs at Phase II or Phase IIB

  • Applicants may now switch between SBIR & STTR Programs. Those who previously were funded under an STTR Phase I award are now eligible to apply for an SBIR Phase II award and vice versa.
  • Those who previously were funded under an STTR Phase II award are now eligible to apply for an SBIR Phase IIB award and vice versa.

View the Application Guide for NIH and Other PHS Agencies for more information on preparing and submitting SBIR & STTR applications.

 


Recently ReleasedThe SBIR Phase IIB Bridge Award RFA is now live. Please apply by April 21, 2014, 5:00PM local time.

How to Apply
For resources and examples of SBIR grant applications and contract proposals, please visit http://sbir.cancer.gov/resource/apply/.

Please visit http://sbir.cancer.gov/ to learn more about the NCI SBIR & STTR Programs.

The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

Sign up to receive updates about
SBIR & STTR funding opportunities at
sbir.cancer.gov